Clinical Trials
22 trialsNCT05640999 2026-05-12
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Canadian Cancer Trials Group
Phase 2 Recruiting
NCT01164150 2026-04-13
Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
Cancer Trials Ireland
Phase 2 Terminated
NCT01244789 2026-04-13
Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Danish Gynecological Cancer Group
Phase 2 Active not recruiting
NCT04393285 2026-03-09
Abemaciclib and Letrozole to Treat Endometrial Cancer
GOG Foundation
Phase 2 Active not recruiting
NCT00053794 2023-08-04
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
Canadian Cancer Trials Group
Phase 2 Completed
NCT00770185 2023-08-04
Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer
Canadian Cancer Trials Group
Phase 2 Completed
NCT00004251 2020-04-06
Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
Canadian Cancer Trials Group
Phase 2 Completed
NCT00331760 2019-02-26
Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
Radiation Therapy Oncology Group
Phase 2 Completed
NCT03005015 2016-12-29
Lenvatinib in Second Line Endometrial Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Withdrawn
NCT00087100 2014-02-14
Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
GOG Foundation
Phase 2 Completed
NCT00085332 2014-01-13
Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
GOG Foundation
Phase 2 Completed
NCT00526149 2013-10-07
BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00003179 2013-06-10
Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
GOG Foundation
Phase 2 Terminated
NCT00003946 2013-06-10
Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
GOG Foundation
Phase 2 Completed
NCT00005643 2013-06-10
Chemotherapy in Treating Patients With Sarcoma of the Uterus
GOG Foundation
Phase 2 Completed
NCT00005861 2013-06-10
Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer
GOG Foundation
Phase 2 Completed
NCT00005031 2013-05-27
Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
GOG Foundation
Phase 2 Completed
NCT00003624 2013-04-11
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
GOG Foundation
Phase 2 Terminated
NCT00003939 2012-09-24
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00022620 2012-09-24
Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00052312 2012-09-24
Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00003127 2012-06-14
S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
SWOG Cancer Research Network
Phase 2 Completed